PA
Profund Advisors Portfolio holdings
AUM
$3.29B
1-Year Est. Return
39.67%
This Fund
S&P 500
1 Year Est. Return
+39.67%
AUM
$3.29B
AUM Growth
+$214M
(+7%)
Holding
1,306
Top Buys
| 1 | +$15.9M | |
| 2 | +$8.37M | |
| 3 | +$6.93M | |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$5.33M |
| 5 |
Seagate
STX
|
+$4.32M |
Top Sells
| 1 | +$28.2M | |
| 2 | +$5.8M | |
| 3 | +$4.35M | |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$3.97M |
| 5 |
Alibaba
BABA
|
+$3.95M |
Sector Composition
| 1 | Technology | 45.99% |
| 2 | Healthcare | 11.64% |
| 3 | Communication Services | 11.05% |
| 4 | Consumer Discretionary | 10.25% |
| 5 | Financials | 4.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Amicus Therapeutics
FOLD
$4.5B
| $2.61M | 0.08% |
183,552
+100,317
|
|
||
152
Vistra
VST
$55.4B
| $2.61M | 0.08% |
16,178
-815
|
|
||
153
United Therapeutics
UTHR
$21.9B
| $2.58M | 0.08% |
5,288
+44
|
|
||
154
AT&T
T
$203B
| $2.57M | 0.08% |
103,431
+7,154
|
|
||
155
BioMarin Pharmaceuticals
BMRN
$11.3B
| $2.57M | 0.08% |
43,178
+8,443
|
|
||
156
Pfizer
PFE
$151B
| $2.54M | 0.08% |
102,174
+16,785
|
|
||
157
TJX Companies
TJX
$180B
| $2.54M | 0.08% |
16,538
-1,514
|
|
||
158
Kraft Heinz
KHC
$28.5B
| $2.52M | 0.08% |
104,002
+7,529
|
|
||
159
Accenture
ACN
$129B
| $2.52M | 0.08% |
9,400
-1,234
|
|
||
160
ServiceNow
NOW
$119B
| $2.52M | 0.08% |
16,454
-2,436
|
|
||
161
Cytokinetics
CYTK
$7.42B
| $2.52M | 0.08% |
39,642
+13,712
|
|
||
162
RTX Corp
RTX
$280B
| $2.5M | 0.08% |
13,658
-1,212
|
|
||
163
Exelixis
EXEL
$10.8B
| $2.5M | 0.08% |
57,050
+6,739
|
|
||
164
Boeing
BA
$179B
| $2.5M | 0.08% |
11,516
-467
|
|
||
165
Biogen
BIIB
$27B
| $2.5M | 0.08% |
14,200
-9,931
|
|
||
166
Praxis Precision Medicines
PRAX
$8.86B
| $2.49M | 0.08% |
8,455
+376
|
|
||
167
Dominion Energy
D
$55.1B
| $2.48M | 0.08% |
42,379
-2,233
|
|
||
168
JD.com
JD
$36B
| $2.48M | 0.08% |
86,267
-20,117
|
|
||
169
DexCom
DXCM
$28.1B
| $2.47M | 0.08% |
37,289
+3,697
|
|
||
170
Incyte
INCY
$19.5B
| $2.46M | 0.07% |
24,911
+3,446
|
|
||
171
Roivant Sciences
ROIV
$19.9B
| $2.45M | 0.07% |
113,033
+6,394
|
|
||
172
BridgeBio Pharma
BBIO
$12.5B
| $2.44M | 0.07% |
31,930
-2,298
|
|
||
173
Krystal Biotech
KRYS
$7.71B
| $2.44M | 0.07% |
9,887
+1,557
|
|
||
174
Halozyme
HALO
$8.19B
| $2.43M | 0.07% |
36,100
+11,469
|
|
||
175
Arrowhead Research
ARWR
$8.98B
| $2.43M | 0.07% |
36,542
+7,108
|
|